Senetek PLC taps Michael Rogers PR

Senetek PLC, a life sciences company focused on anti-aging technologies, has tapped Michael Rogers PR for the launch of its Pyratine-6 product. Terms of the deal were not disclosed.

Michael Rogers PR will be responsible for corporate positioning, physician outreach and consumer education. “Our target is women 40 years and older,” said Michael Rogers, president. “We'll do some advertising in the trades to start, and we're creating an education campaign for physicians, as well as a consumer campaign,” he said, noting that beauty editors will be targeted, and a forum will be created where women can try the product and blog about it.

Pyratine-6 is Senetek's second generation cytokinin-based skincare treatment used to combat the signs of aging. Senetek developed the Kinerase skincare line in the 1990s. Pyratine-6 does not require a prescription, although it can not be purchased directly in a pharmacy. 

You must be a registered member of MMM to post a comment.
close

Next Article in Features


Email Newsletters


Specialty medicines continue to be a hot category, one in which spending has surged behind products that treat medicine's most complex diseases. This eBook lays out the needs and hurdles along the specialty drug pathway, explaining how stakeholders are working to get meds into patients' hands and ease their experience. Click here to download.